45
Quince Therapeutics, Inc. raises $7.4M under Reg D
Company raise · Pre-first close · Offering $7.4M · SOUTH SAN FRANCISCO, CA · filed 2026-06-11
Placement agent engagedBusiness combination
57
Quince Therapeutics, Inc. raises $11.5M under Reg D
Company raise · Raising · SOUTH SAN FRANCISCO, CA · Form D filed 2025-07-01
$10M+ raiseFirst raise on EDGARPlacement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Una Ryan | Director |
| David Lamond | Director |
| Christopher Senner | Director |
| Charles Ryan | Executive Officer |
| Margi McLoughlin | Director |
| June Bray | Director |
| Luca Benatti | Director |
| Brendan Hannah | Executive Officer |
| Dirk Thye | Executive Officer, Director |
| Rajiv Patni | Director |
Signed by Brendan Hannah, Chief Business Officer.
Placement agents / sales compensation: Citizens JMP Securities, LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
60
Quince Therapeutics, Inc. raises $114.7M under Reg D
Company raise · Raising · Offering $186.4M · Sold $114.7M · SOUTH SAN FRANCISCO, CA · filed 2026-06-11
Placement agent engaged